Background: Botulinum toxin is an attenuated neurotoxin of Clostridium Botulinum gram positive bacterial, which is used in medication sialorrhea, cervical dystonia, hyperhidrosis and non-surgical cosmetic operation (aesthetic) such as facial wrinkles and reduced the bulky appearance hypertrophied of masseter muscle. This study was designed to revealed the effect of zygomiticus inoculation of botulinum toxin B in zygomatic muscle of rats on zygomatic bone.

Methods: A total of 25 male albino rats (200-260 gm) were injected facial intramuscular by a single dose of 2.5 U/ botulinum toxin B. All experimental groups (4 groups, 5 each) were kept survived to the end period and sacrificed by time period [group 1 (G1)=14; group 2 (G2)=30; group 3 (G3)=45, and group 4 (G4)=60 days] post injection, moreover, 5 animals were administered nothing and kept as a control group till 60 days elapsed. Animals were killed by intense dose of chloroform and rats facial zygomatic bone removed.

Results: Zygomatic bone of G1 showed irregular boney border, degenerated osteocytes, woven collagen bundles within collar bone, reddish bone matrix and detachment of fibrous layer of periosteum in G2 results showed disappearance of osteogenic cells, lacunae devoid osteocytes, and aggregated of necrotic elements of bone tissue. In G3 groups showed great crack, disorganization of collagen bundles atrophied osteocytes the matrix of bone had necrotic areas of osteocytes, fragments of bone also demonstrated. G4 group showed massive crack underneath degenerated periosteum of bone, tunnel like furrow, filled up with cellular debris and osteogenic debris within Howship's lacunae.

Conclusion: In this present study we summarized the effect of paralyzed facial muscle by botulinum toxin B on facial bone of rats induced, secondary osteoporosis represented as irregular bone border degeneration of osteocytes, crack appeared in bony matrix, decreases in amounts of collagen bundles and separation of periosteum.

Download full-text PDF

Source

Publication Analysis

Top Keywords

botulinum toxin
16
zygomatic bone
12
collagen bundles
12
bone
11
zygomatic
5
botulinum
5
facial
5
group
5
osteocytes
5
incuolation botulinum
4

Similar Publications

As the face ages, the skin, fat, muscle, and fascia descend, and the underlying bone, cartilage, and teeth may lose mass. Oculofacial aging is a multifactorial process that is influenced by genetic, environmental, and lifestyle factors. This review summarizes the patterns of oculofacial aging that are observed across populations, including variations in periorbital hollowing, eyelid ptosis, and skin elasticity.

View Article and Find Full Text PDF

Repetitive intramuscular injections of botulinum neurotoxin (BoNT) have become the treatment of choice for a variety of disease entities. But with the onset of BoNT therapy, the natural course of a disease is obscured. Nevertheless, the present study tries to analyze patients' "suspected" course of disease severity under the assumption that no BoNT therapy had been performed and compares that with the "experienced" improvement during BoNT treatment.

View Article and Find Full Text PDF

Botulinum toxin (BoNT), the most potent substance known to humans, likely evolved not to kill but to serve other biological purposes. While its use in cosmetic applications is well known, its medical utility has become increasingly significant due to the intricacies of its structure and function. The toxin's structural complexity enables it to target specific cellular processes with remarkable precision, making it an invaluable tool in both basic and applied biomedical research.

View Article and Find Full Text PDF

Background: Botulinum toxin is an attenuated neurotoxin of Clostridium Botulinum gram positive bacterial, which is used in medication sialorrhea, cervical dystonia, hyperhidrosis and non-surgical cosmetic operation (aesthetic) such as facial wrinkles and reduced the bulky appearance hypertrophied of masseter muscle. This study was designed to revealed the effect of zygomiticus inoculation of botulinum toxin B in zygomatic muscle of rats on zygomatic bone.

Methods: A total of 25 male albino rats (200-260 gm) were injected facial intramuscular by a single dose of 2.

View Article and Find Full Text PDF

The study aimed to identify expert opinions and obtain recommendations on the management of post-stroke hemiplegic shoulder pain (HSP) and treatment with botulinum toxin A (BoNT-A). A multicenter Delphi study was conducted using an online survey designed by a committee of experts with at least 10 years of experience in post-stroke HSP management with BoNT-A in Spain. Forty-seven panelists (specialists with at least 5 years of experience in post-stroke HSP management with BoNT-A) rated their level of agreement in two rounds based on acceptance by ≥66.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!